BR112012031095A2 - método para preparação de uma composição de asiaticoside altamente pura a partir de centella asiatica de um método para seu uso - Google Patents

método para preparação de uma composição de asiaticoside altamente pura a partir de centella asiatica de um método para seu uso

Info

Publication number
BR112012031095A2
BR112012031095A2 BR112012031095A BR112012031095A BR112012031095A2 BR 112012031095 A2 BR112012031095 A2 BR 112012031095A2 BR 112012031095 A BR112012031095 A BR 112012031095A BR 112012031095 A BR112012031095 A BR 112012031095A BR 112012031095 A2 BR112012031095 A2 BR 112012031095A2
Authority
BR
Brazil
Prior art keywords
effective amount
therapeutically effective
oral administration
asiaticoside
asiaticoside composition
Prior art date
Application number
BR112012031095A
Other languages
English (en)
Other versions
BR112012031095B1 (pt
Inventor
Sunil Bhaskaran
Mohan Vishwaraman
Original Assignee
Indus Biotech Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indus Biotech Private Ltd filed Critical Indus Biotech Private Ltd
Publication of BR112012031095A2 publication Critical patent/BR112012031095A2/pt
Publication of BR112012031095B1 publication Critical patent/BR112012031095B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

método para preparação de uma composição de asiaticoside altamente pura a partir de centella asiatica de um método para seu uso. a presente invenção divulga uma composição de asiaticoside comercialmente viável com no mínimo 99% de pureza e derivada da planta centella asiatica, além de seu processo de fabricação: a presente invenção ainda instrui sobre o método e os modelos para a administração por via oral de uma quantidade terapeuticamente eficaz dos modelos de asiaticoside para administração por via oral de uma quantidade terapeuticamente eficaz da composição de asiaticoside para o tratamento de doenças inflamatórias intestinais como colite ulcerativa, doença de crohn e complicações associadas às doenças inflamatórias intestinais, como hemorroidas, fistulas e fissuras anais. a invenção também fornece um método e modelo para a administração por via oral de uma quantidade terapeuticamente eficaz da composição de asiaticoside para o tratamento de helicobacter pylori. a invenção ainda fornece um método e os modelos para a administração por via oral de uma quantidade terapeuticamente eficaz da composição de asiaticoside para a prevenção de câncer de cólon, doenças gástricas e carcinoma gástrico.
BR112012031095A 2010-06-10 2010-08-31 método para preparação de uma composição de asiaticoside altamente pura a partir de centella asiatica de um método para seu uso BR112012031095B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1760MU2010 2010-06-10
PCT/IN2010/000575 WO2011154966A1 (en) 2010-06-10 2010-08-31 A method for preparation of highly pure asiaticoside composition from centella asiatica and a method of use thereof

Publications (2)

Publication Number Publication Date
BR112012031095A2 true BR112012031095A2 (pt) 2017-08-01
BR112012031095B1 BR112012031095B1 (pt) 2020-05-05

Family

ID=54155655

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012031095A BR112012031095B1 (pt) 2010-06-10 2010-08-31 método para preparação de uma composição de asiaticoside altamente pura a partir de centella asiatica de um método para seu uso

Country Status (10)

Country Link
US (2) US9139608B2 (pt)
EP (1) EP2582376B1 (pt)
JP (2) JP5913297B2 (pt)
KR (2) KR20130009872A (pt)
CN (2) CN103079573B (pt)
AU (1) AU2010354973B2 (pt)
BR (1) BR112012031095B1 (pt)
CA (2) CA2933339C (pt)
RU (1) RU2565410C2 (pt)
WO (1) WO2011154966A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20120631A1 (it) * 2012-11-19 2014-05-20 Vi Rus Srl Composizione di una schiuma detergente a base di estratti naturali per la detersione dell'area perianale.
EP3172881B1 (en) * 2014-07-25 2020-09-02 Telefonaktiebolaget LM Ericsson (publ) Lawful intercept systems and methods in li systems
DK3484457T3 (da) * 2016-07-17 2023-07-10 Oneness Biotech Co Ltd Topisk formulering til fremme af sårheling
CN108398493B (zh) * 2017-02-08 2021-05-28 桂林三金药业股份有限公司 一种积雪草药材及其提取物与制剂的质量检测方法
CN113573777A (zh) * 2019-03-28 2021-10-29 国立大学法人东北大学 癌的预防或治疗剂
CN109998488B (zh) * 2019-04-13 2022-08-02 中国医学科学院北京协和医院 克罗恩病和肠道溃疡型淋巴瘤的鉴别模型及构建方法
CN110812396B (zh) * 2019-11-26 2024-06-25 广州中医药大学第一附属医院 一种用于治疗溃疡性结肠炎的中药组合物及其制备方法和应用
CN112773745A (zh) * 2021-02-06 2021-05-11 广州贝塔健康生物科技有限公司 一种积雪草苷提取物制备方法及在化妆品中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383171A3 (en) * 1989-02-11 1991-07-24 Hoechst Aktiengesellschaft 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
CH690817A5 (de) * 1996-09-03 2001-01-31 Flachsmann Ag Emil Verfahren zur Herstellung eines stabilen, homogenen, von Folgeprodukten freien oder nahezu freien Extraktes.
KR100228873B1 (ko) 1997-03-24 1999-11-01 강재헌 센텔라아시아티카에서 분리한 아시아티코사이드와 마테카소 사이드의 수용성 추출물을 함유한 간세포 및 항간섬유화 치료제
US6228387B1 (en) * 2000-01-27 2001-05-08 Murray Borod Integrated comprehensive hemorrhoid treatment compositions and regimen
MY138883A (en) * 2000-08-29 2009-08-28 Government Of Malaysia As Represented By The Ministry Of Science Tehnology And Innovation Malaysia Use of asiatic acid for treatment of cencer
JP2002265375A (ja) * 2001-03-13 2002-09-18 Inabata Koryo Kk 唾液分泌促進剤及びこれを含有した食品組成物並びに口腔用組成物
RU2218392C1 (ru) * 2002-07-01 2003-12-10 Богданов Николай Иванович Установка для выращивания хлореллы
FR2848117B1 (fr) * 2002-12-10 2006-08-04 Roche Consumer Health Ltd Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
CN1264518C (zh) 2003-01-27 2006-07-19 上海海天医药科技开发有限公司 积雪草甙在制备药物中的用途
ITTO20030126A1 (it) 2003-02-20 2004-08-21 Medestea Res And Production S R L Composizione di integratore alimentare atta a favorire l'assorbimento del ferro.
CN1439376A (zh) 2003-04-01 2003-09-03 上海医药工业研究院 一种抗肺肝纤维化的积雪草苷中药制剂
CN100467025C (zh) * 2004-06-09 2009-03-11 北京苏里曼医药科技有限公司 积雪草总苷、积雪草苷或羟基积雪草苷在制备防治心、脑血管疾病药物中的用途
TWI361074B (en) * 2005-12-22 2012-04-01 Dev Center Biotechnology Plant extracts for enhancing healing of wounds,and the preparation process and use thereof
EP1925310B1 (en) * 2006-11-24 2015-03-25 Development Center For Biotechnology Plant extracts from Plectranthus and Centella for treating skin disorders and accelerating wound healing in diabetic patients
BRPI0806793B8 (pt) 2007-02-12 2021-05-25 Indus Biotech Private Ltd composição para a inibição seletiva da absorção de serotonina e processo da mesma
US8449924B2 (en) 2007-08-29 2013-05-28 Development Center For Biotechnology Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
CN101129393A (zh) 2007-09-11 2008-02-27 程雪翔 积雪苷口服液及其制备方法
EP2231139B1 (en) * 2008-01-11 2015-02-25 Shanghai Institute of Pharmaceutical Industry Therapeutic formulations based on asiatic acid and selected salts thereof

Also Published As

Publication number Publication date
KR20130009872A (ko) 2013-01-23
EP2582376A1 (en) 2013-04-24
KR101632369B1 (ko) 2016-06-21
EP2582376A4 (en) 2014-04-23
CN103079573A (zh) 2013-05-01
CA2933339A1 (en) 2011-12-15
AU2010354973A1 (en) 2012-12-20
EP2582376B1 (en) 2018-05-23
CA2802154C (en) 2017-02-28
US20130089605A1 (en) 2013-04-11
BR112012031095B1 (pt) 2020-05-05
US9139608B2 (en) 2015-09-22
JP2013534519A (ja) 2013-09-05
AU2010354973B2 (en) 2015-01-22
JP2016006115A (ja) 2016-01-14
KR20150054003A (ko) 2015-05-19
CA2933339C (en) 2019-01-22
CA2802154A1 (en) 2011-12-15
JP5913297B2 (ja) 2016-04-27
RU2012155141A (ru) 2014-07-20
WO2011154966A1 (en) 2011-12-15
CN104940217A (zh) 2015-09-30
RU2565410C2 (ru) 2015-10-20
US20150342976A1 (en) 2015-12-03
CN103079573B (zh) 2016-06-15

Similar Documents

Publication Publication Date Title
BR112012031095A2 (pt) método para preparação de uma composição de asiaticoside altamente pura a partir de centella asiatica de um método para seu uso
AU2016202421B2 (en) Method of treating neurological conditions with cardiac glycosides
HRP20191919T1 (hr) Donori nitroksila sa poboljšanim terapijskim indeksom
BR112012024379A2 (pt) "peptídeos glucagon, seu uso, bem como composição farmacêutica"
BR112014006684A2 (pt) análogos de glucagon
WO2011027257A3 (en) Pcsk9 vaccine
IN2014DN08440A (pt)
CN102380025A (zh) 一种川贝止咳糖浆的配制方法
CA2863829A1 (en) Oral unit dosage forms and uses of same for the treatment of gaucher disease
CN100558378C (zh) 一种治疗高血压的中药
CN104116956A (zh) 一种麻醉科用于治疗癌性疼痛的药物组合物
BR112013030960B8 (pt) Uso de uma composição de asiaticosídeo e madecassosídeo, na fabricação de um medicamento para controlar a hipercortisolemia, os distúrbios de cefaleia, a dor neuropática e os distúrbios relacionados
NZ702155A (en) Novel pharmacological use of cimicifuga extract
WO2011107283A3 (de) Formulierungen von taurolidin und verfahren zu seiner herstellung
CN101919954A (zh) 山苁蓉药酒
CN104644828A (zh) 治湿疹的外用中药
CN105380987A (zh) 治麻疹的中药配方
CN105535150A (zh) 一种治疗鼻腔炎性疾病的中药及其制备方法
TW200740449A (en) Preparation of alkali soluble polysaccharides from Panax quinquefolium, process for making the same and use in enhancing immunity
CN102895314B (zh) 一种具有减肥降脂作用的药物
CN105396082A (zh) 一种用于治疗失眠多梦的中药组合物
CN107961361A (zh) 一种治疗慢性胃肠炎的中药配方
CN101766669A (zh) 治疗跌打损伤的中药
CN106822299A (zh) 一种降胆固醇的中医药物配方
BR112012011818A2 (pt) "uso de um polímero de polissacarídeo, e, preparação na forma de uma dosagem líquida para aplicação tópica aerossolizada."

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/08/2010, OBSERVADAS AS CONDICOES LEGAIS.